BioCapital expands the BioLionaire Scientist series into the strategic layer of biotechnology — where discovery becomes infrastructure, infrastructure becomes platform, and platform becomes capital.
This volume examines the evolving relationship between scientific intelligence and venture creation. It moves beyond laboratory discovery to analyze how translational positioning, intellectual property protection, startup architecture, and investor alignment determine whether deep biology becomes investable biotechnology.
Rather than presenting entrepreneurship as a motivational concept, this book frames it as a structural discipline. It connects research strategy to capital formation through the “BioLionaire mindset,” demonstrating how scientists can think in systems: discovery, protection, validation, infrastructure, branding, and long-term value creation.
From cancer R&D infrastructure and IP defense to startup blueprints and the future of deep biology investing, BioCapital provides a serious framework for researchers who aim to build durable biotech platforms rather than isolated publications.
This volume is written for PhD scientists, postdoctoral researchers, clinician-investigators, deep-tech founders, translational teams, and early-stage biotechnology builders who want to understand how research evolves into venture-grade platforms. It is also appropriate for academic innovation offices, biotech incubators, and institutional libraries supporting entrepreneurship in science.
Part I - The Science-to-Business
Chapter 1 — The New Age of Biotech Intelligence
Chapter 2 — The Translational Lens
Chapter 3 — The BioLionaire Mindset
Part II - Building the Biotech Engine
Chapter 4 — The Next Infrastructure For Cancer R&D
Chapter 5 — Protecting the Discovery
Chapter 6 — The Startup Blueprint
Chapter 7 — From Bench to Brand
Part III - Investing in the Future
Chapter 8 — Deep Biology Startups
Chapter 9 — Scientists Who Built Capital
Chapter 10 — BioCapital 2035
Appendices
Appendix A — A Two-Page Map from Laboratory Discovery to Investable Venture
Appendix B — Investor Lens Boxes
Appendix C — Turn Your Research into a Venture in 12 Months (Checklist)
Appendix D — Example SBIR Phase I Grant Proposal
Glossary
Index
Companies Discussed in this Volume
Essential Reading
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 53711404
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 53711404-n
Quantité disponible : Plus de 20 disponibles
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. Print on Demand. N° de réf. du vendeur I-9798277029312
Quantité disponible : Plus de 20 disponibles
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. BioCapital expands the BioLionaire Scientist series into the strategic layer of biotechnology - where discovery becomes infrastructure, infrastructure becomes platform, and platform becomes capital.This volume examines the evolving relationship between scientific intelligence and venture creation. It moves beyond laboratory discovery to analyze how translational positioning, intellectual property protection, startup architecture, and investor alignment determine whether deep biology becomes investable biotechnology.Rather than presenting entrepreneurship as a motivational concept, this book frames it as a structural discipline. It connects research strategy to capital formation through the "BioLionaire mindset," demonstrating how scientists can think in systems: discovery, protection, validation, infrastructure, branding, and long-term value creation.From cancer R&D infrastructure and IP defense to startup blueprints and the future of deep biology investing, BioCapital provides a serious framework for researchers who aim to build durable biotech platforms rather than isolated publications.Who This Book Is ForThis volume is written for PhD scientists, postdoctoral researchers, clinician-investigators, deep-tech founders, translational teams, and early-stage biotechnology builders who want to understand how research evolves into venture-grade platforms. It is also appropriate for academic innovation offices, biotech incubators, and institutional libraries supporting entrepreneurship in science.Table of ContentsPart I - The Science-to-BusinessChapter 1 - The New Age of Biotech IntelligenceChapter 2 - The Translational LensChapter 3 - The BioLionaire MindsetPart II - Building the Biotech EngineChapter 4 - The Next Infrastructure For Cancer R&DChapter 5 - Protecting the DiscoveryChapter 6 - The Startup BlueprintChapter 7 - From Bench to BrandPart III - Investing in the FutureChapter 8 - Deep Biology StartupsChapter 9 - Scientists Who Built CapitalChapter 10 - BioCapital 2035AppendicesAppendix A - A Two-Page Map from Laboratory Discovery to Investable VentureAppendix B - Investor Lens BoxesAppendix C - Turn Your Research into a Venture in 12 Months (Checklist)Appendix D - Example SBIR Phase I Grant ProposalGlossaryIndexCompanies Discussed in this VolumeEssential Reading This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9798277029312
Quantité disponible : 1 disponible(s)
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798277029312
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798277029312
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 53711404-n
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 53711404
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. BioCapital expands the BioLionaire Scientist series into the strategic layer of biotechnology - where discovery becomes infrastructure, infrastructure becomes platform, and platform becomes capital.This volume examines the evolving relationship between scientific intelligence and venture creation. It moves beyond laboratory discovery to analyze how translational positioning, intellectual property protection, startup architecture, and investor alignment determine whether deep biology becomes investable biotechnology.Rather than presenting entrepreneurship as a motivational concept, this book frames it as a structural discipline. It connects research strategy to capital formation through the "BioLionaire mindset," demonstrating how scientists can think in systems: discovery, protection, validation, infrastructure, branding, and long-term value creation.From cancer R&D infrastructure and IP defense to startup blueprints and the future of deep biology investing, BioCapital provides a serious framework for researchers who aim to build durable biotech platforms rather than isolated publications.Who This Book Is ForThis volume is written for PhD scientists, postdoctoral researchers, clinician-investigators, deep-tech founders, translational teams, and early-stage biotechnology builders who want to understand how research evolves into venture-grade platforms. It is also appropriate for academic innovation offices, biotech incubators, and institutional libraries supporting entrepreneurship in science.Table of ContentsPart I - The Science-to-BusinessChapter 1 - The New Age of Biotech IntelligenceChapter 2 - The Translational LensChapter 3 - The BioLionaire MindsetPart II - Building the Biotech EngineChapter 4 - The Next Infrastructure For Cancer R&DChapter 5 - Protecting the DiscoveryChapter 6 - The Startup BlueprintChapter 7 - From Bench to BrandPart III - Investing in the FutureChapter 8 - Deep Biology StartupsChapter 9 - Scientists Who Built CapitalChapter 10 - BioCapital 2035AppendicesAppendix A - A Two-Page Map from Laboratory Discovery to Investable VentureAppendix B - Investor Lens BoxesAppendix C - Turn Your Research into a Venture in 12 Months (Checklist)Appendix D - Example SBIR Phase I Grant ProposalGlossaryIndexCompanies Discussed in this VolumeEssential Reading This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798277029312
Quantité disponible : 1 disponible(s)